Related references
Note: Only part of the references are listed.Lecanemab in Early Alzheimer's Disease
Christopher H. van Dyck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
TGF-beta signal transduction: biology, function and therapy for diseases
Yan Tie et al.
MOLECULAR BIOMEDICINE (2022)
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease A Randomized Clinical Trial
Tanya Simuni et al.
JAMA NEUROLOGY (2021)
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease
Livia La Barbera et al.
PROGRESS IN NEUROBIOLOGY (2021)
CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease
Alan J. Fowler et al.
NEUROLOGY-GENETICS (2021)
Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
Fernando L. Pagan et al.
MOVEMENT DISORDERS (2021)
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease A Phase 2 Randomized Clinical Trial
Fernando. L. Pagan et al.
JAMA NEUROLOGY (2020)
Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases
Alan J. Fowler et al.
HUMAN MOLECULAR GENETICS (2020)
Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study
Abhinandan Batra et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2020)
Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration
Alan J. Fowler et al.
DRUGS IN R&D (2019)
The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus
Manuel Chiusa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Biological Functions of Autophagy Genes: A Disease Perspective
Beth Levine et al.
CELL (2019)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation et al.
NATURE MEDICINE (2019)
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease
Fernando L. Pagan et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model
Saebom Lee et al.
HUMAN MOLECULAR GENETICS (2018)
Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans
Marcello D'Amelio et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tau clearance improves astrocytic function and brain glutamate-glutamine cycle
Michaeline L. Hebron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease
Rachel E. Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Rebecca F. Gottesman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Alzheimer's disease: A matter of blood-brain barrier dysfunction?
Axel Montagne et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Discoidin domain receptor inhibition reduces neuropathology and attenuates inflammation in neurodegeneration models
Michaeline Hebron et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis
Corina M. Borza et al.
MATRIX BIOLOGY (2017)
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
A. H. Ashok et al.
MOLECULAR PSYCHIATRY (2017)
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Costantino Iadecola
NEURON (2017)
Synaptic Transmission Optimization Predicts Expression Loci of Long-Term Plasticity
Rui Ponte Costa et al.
NEURON (2017)
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease
Annalisa Nobili et al.
NATURE COMMUNICATIONS (2017)
The endocytic pathway in microglia during health, aging and Alzheimer's disease
Santiago Sole-Domenech et al.
AGEING RESEARCH REVIEWS (2016)
Nilotinib Effects in Parkinson's Disease and Dementia with Lewy Bodies
Fernando Pagan et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Heather M. Snyder et al.
ALZHEIMERS & DEMENTIA (2015)
Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons
Wei-Na Yang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
DDR1 may play a key role in destruction of the blood-brain barrier after cerebral ischemia-reperfusion
Mingxia Zhu et al.
NEUROSCIENCE RESEARCH (2015)
Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy
Laura J. Blair et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance
Irina Lonskaya et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models
Irina Lonskaya et al.
MOLECULAR NEURODEGENERATION (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Tyrosine kinase inhibition facilitates autophagic SNCA/α-synuclein clearance
Michaeline L. Hebron et al.
AUTOPHAGY (2013)
Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance
Irina Lonskaya et al.
EMBO MOLECULAR MEDICINE (2013)
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinsons disease models
Michaeline L. Hebron et al.
HUMAN MOLECULAR GENETICS (2013)
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Joanna M. Wardlaw et al.
LANCET NEUROLOGY (2013)
Ubiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance
Irina Lonskaya et al.
PLOS ONE (2013)
Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production
M. E. Roberts et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
c-Abl in Neurodegenerative Disease
Sarah D. Schlatterer et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease
Syed Z. Imam et al.
JOURNAL OF NEUROSCIENCE (2011)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
Berislav V. Zlokovic
NATURE REVIEWS NEUROSCIENCE (2011)
Genetic association to the amyloid plaque associated protein gene COL25A1 in Alzheimer's disease
Charlotte Forsell et al.
NEUROBIOLOGY OF AGING (2010)
COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo
Ying Tong et al.
NEUROGENETICS (2010)
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
Han Seok Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Discoidin Domain Receptor 1 on Bone Marrow-Derived Cells Promotes Macrophage Accumulation During Atherogenesis
Christopher Franco et al.
CIRCULATION RESEARCH (2009)
Altered Subcellular Distribution of c-Abl in Alzheimer's Disease
Zheng Jing et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Discoidin domain receptor 1 (Ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice
Christopher Franco et al.
CIRCULATION RESEARCH (2008)
Brain endothelial cell-cell junctions: How to Open the blood brain barrier
Svetlana M. Stamatovic et al.
CURRENT NEUROPHARMACOLOGY (2008)
Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease
Martin Flamant et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis
Carmel Avivi-Green et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
被撤回的出版物: Involvement of discoidin domain receptor 1 in the deterioration of pulmonary sarcoidosis (Retracted article. See vol 39, pg. 380, 2008)
W Matsuyama et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
被撤回的出版物: Activation of discoidin domain receptor 1 on CD14-positive pronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis (Retracted Article. See vol 181, pg 6672, 2008)
W Matsuyama et al.
JOURNAL OF IMMUNOLOGY (2005)
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
E Weisberg et al.
CANCER CELL (2005)
Mostly separate distributions of CLAC- versus Aβ40-or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of β-amyloid deposits
H Kowa et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Share Paper
